Steve Gallup

Steve Gallup is a seasoned professional in the rare disease sector with extensive experience in business management and clinical marketing. Currently serving as a Rare Disease Territory Business Manager at argenx since September 2021, Steve is involved in the market preparation and launch of a novel neuromuscular therapy and contributes to the US GM council for strategic guidance. Prior roles include Rare Disease Account Executive at Biogen, where Steve launched Spinraza and established over twenty sites of care, and Clinical Science Associate at Genzyme Genetics, focusing on enzyme replacement therapies. Steve's background also includes positions at Synageva BioPharma Corp. and MedImmune, underscoring a strong foundation in clinical marketing and strategic collaboration with key opinion leaders in the field. Steve holds a BS in Pharmacology from UC Santa Barbara.